| Primary |
| Hypertension |
70.9% |
| Glucose Tolerance Impaired |
6.2% |
| Cardiovascular Disorder |
5.4% |
| Product Used For Unknown Indication |
2.7% |
| Diabetes Mellitus |
1.8% |
| Cardiac Failure |
1.7% |
| Acute Coronary Syndrome |
1.4% |
| Cardiac Failure Chronic |
1.0% |
| Depression |
1.0% |
| Dyslipidaemia |
1.0% |
| Hyperlipidaemia |
0.9% |
| Acute Myocardial Infarction |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Pain |
0.8% |
| Coronary Artery Disease |
0.7% |
| Nephrotic Syndrome |
0.7% |
| Prophylaxis |
0.7% |
| Asthma |
0.6% |
| Myocardial Ischaemia |
0.6% |
| Arrhythmia |
0.5% |
|
| Death |
11.6% |
| Renal Failure Acute |
10.2% |
| Blood Pressure Diastolic Decreased |
9.3% |
| Hyperkalaemia |
7.0% |
| Syncope |
5.6% |
| Hypotension |
5.1% |
| Oligohydramnios |
5.1% |
| Tinnitus |
5.1% |
| Vomiting |
5.1% |
| Angioedema |
4.7% |
| Fall |
3.7% |
| Renal Failure Chronic |
3.7% |
| Diarrhoea |
3.3% |
| Hyponatraemia |
3.3% |
| Renal Failure |
3.3% |
| Blood Pressure Decreased |
2.8% |
| Blood Pressure Increased |
2.8% |
| Dyspnoea |
2.8% |
| Nausea |
2.8% |
| Renal Impairment |
2.8% |
|
| Secondary |
| Hypertension |
28.2% |
| Cardiac Failure Chronic |
15.6% |
| Product Used For Unknown Indication |
11.5% |
| Drug Use For Unknown Indication |
6.4% |
| Type 2 Diabetes Mellitus |
5.7% |
| Cardiac Failure Congestive |
5.3% |
| Glucose Tolerance Impaired |
3.6% |
| Cardiovascular Disorder |
3.6% |
| Diabetes Mellitus |
3.0% |
| Cardiac Failure |
3.0% |
| Hyperlipidaemia |
2.1% |
| Depression |
1.8% |
| Coronary Artery Disease |
1.7% |
| Insomnia |
1.5% |
| Asthma |
1.4% |
| Cough |
1.3% |
| Benign Prostatic Hyperplasia |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Atrial Fibrillation |
0.9% |
| Prophylaxis |
0.9% |
|
| Renal Failure Acute |
9.9% |
| Small Intestinal Haemorrhage |
7.5% |
| Vomiting |
7.1% |
| Completed Suicide |
6.6% |
| Pancreatitis Acute |
6.6% |
| Renal Failure |
6.1% |
| Hyperkalaemia |
5.9% |
| Syncope |
5.4% |
| Tinnitus |
4.9% |
| Atrial Fibrillation |
4.5% |
| Blood Pressure Diastolic Decreased |
4.5% |
| Death |
4.5% |
| Concomitant Disease Progression |
4.2% |
| Hyponatraemia |
3.8% |
| Lower Respiratory Tract Infection |
3.3% |
| Pneumonia |
3.3% |
| Thrombocytopenia |
3.3% |
| Cardiac Failure |
3.1% |
| Hypovolaemia |
2.8% |
| Memory Impairment |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.6% |
| Drug Use For Unknown Indication |
20.2% |
| Hypertension |
20.2% |
| Rheumatoid Arthritis |
6.7% |
| Diabetes Mellitus |
3.7% |
| Prophylaxis |
3.2% |
| Type 2 Diabetes Mellitus |
3.1% |
| Pain |
2.6% |
| Smoking Cessation Therapy |
2.4% |
| Depression |
2.2% |
| Blood Cholesterol Increased |
2.2% |
| Atrial Fibrillation |
2.1% |
| Insomnia |
1.6% |
| Osteoporosis |
1.3% |
| Hiv Infection |
1.2% |
| Blood Pressure |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Hyperlipidaemia |
1.2% |
| Breast Cancer |
1.1% |
| Cardiac Disorder |
1.0% |
|
| Vomiting |
12.1% |
| Weight Increased |
7.2% |
| Weight Decreased |
6.6% |
| Nausea |
6.4% |
| Renal Failure Acute |
6.0% |
| Renal Failure |
5.8% |
| Pain In Extremity |
5.3% |
| Drug Ineffective |
5.1% |
| Myocardial Infarction |
4.9% |
| Somnolence |
4.6% |
| Rash |
4.0% |
| Oedema Peripheral |
3.8% |
| Pneumonia |
3.8% |
| Rhabdomyolysis |
3.8% |
| Syncope |
3.8% |
| Pyrexia |
3.6% |
| Tremor |
3.5% |
| Insomnia |
3.4% |
| Thrombocytopenia |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
|
| Interacting |
| Hypertension |
32.1% |
| Product Used For Unknown Indication |
18.9% |
| Convulsion |
5.0% |
| Arrhythmia |
3.8% |
| Osteitis |
3.8% |
| Blood Pressure Abnormal |
3.1% |
| Essential Hypertension |
3.1% |
| Ingrowing Nail |
3.1% |
| Prophylaxis |
3.1% |
| Renal Disorder |
3.1% |
| Abnormal Behaviour |
2.5% |
| Angina Pectoris |
2.5% |
| Cardiac Failure |
2.5% |
| Gout |
2.5% |
| Drug Use For Unknown Indication |
1.9% |
| Erectile Dysfunction |
1.9% |
| Flushing |
1.9% |
| Heart Rate Abnormal |
1.9% |
| Hypertensive Heart Disease |
1.9% |
| Ascites |
1.3% |
|
| Renal Failure Acute |
13.2% |
| Fatigue |
10.5% |
| Drug Interaction |
7.9% |
| Hyponatraemia |
7.9% |
| Overdose |
7.9% |
| Rhabdomyolysis |
7.9% |
| Drug Effect Decreased |
5.3% |
| Hypertension |
5.3% |
| Syncope |
5.3% |
| Blood Glucose Fluctuation |
2.6% |
| Diarrhoea |
2.6% |
| Dizziness |
2.6% |
| Dyspnoea |
2.6% |
| Headache |
2.6% |
| Heart Rate Increased |
2.6% |
| Hypokalaemia |
2.6% |
| Lactic Acidosis |
2.6% |
| Myocardial Infarction |
2.6% |
| Oligohydramnios |
2.6% |
| Palpitations |
2.6% |
|